Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026)

Pharma-Bio Serv (PBSV) posted Dividends payables of $1.7 million for Q1 2026, down 0.56% on a QoQ basis from $1.7 million in Q1 2021.

Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026) Analysis & Trends

Pharma-Bio Serv's Dividends payables history runs 3 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • Quarterly Dividends payables changed N/A year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $1.7 million (changed N/A YoY) and the FY2019 annual result came in at $1.7 million, changed N/A from the prior year.
  • Dividends payables was $1.7 million for Q1 2026 at Pharma-Bio Serv, down from $1.7 million in the prior quarter.
  • Across five years, Dividends payables topped out at $1.7 million in Q1 2026 and bottomed at $1.7 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Veeva Systems 31.94 Bn 24.62 Bn 662.02 Mn -
2 BrightSpring Health Services 14.72 Bn 13.82 Bn 482.22 Mn -
3 Healthequity 8.33 Bn 8.07 Bn 256.31 Mn -
4 Hinge Health 5.94 Bn 5.63 Bn 154.23 Mn -
5 10x Genomics 5.92 Bn 5.38 Bn 106.18 Mn -
6 MiniMed 4.47 Bn 4.17 Bn 480.00 Mn -
7 Waystar Holding 4.43 Bn 4.37 Bn 216.84 Mn -
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn -
9 Privia Health 3.11 Bn 2.69 Bn - -
10 Pharma-Bio Serv 13.28 Mn 4.81 Mn 902,041.00 -

Historic Data

Download Data
DateValue
Jan 31, 2026 1.72 Mn
Jan 31, 2021 1.73 Mn
Oct 31, 2019 1.73 Mn